74 related articles for article (PubMed ID: 17118362)
1. Kinetics, inhibition and oligomerization of Epstein-Barr virus protease.
Buisson M; Rivail L; Hernandez JF; Jamin M; Martinez J; Ruigrok RW; Burmeister WP
FEBS Lett; 2006 Dec; 580(28-29):6570-8. PubMed ID: 17118362
[TBL] [Abstract][Full Text] [Related]
2. Functional determinants of the Epstein-Barr virus protease.
Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
[TBL] [Abstract][Full Text] [Related]
3. New insights on the role of the gamma-herpesvirus uracil-DNA glycosylase leucine loop revealed by the structure of the Epstein-Barr virus enzyme in complex with an inhibitor protein.
Géoui T; Buisson M; Tarbouriech N; Burmeister WP
J Mol Biol; 2007 Feb; 366(1):117-31. PubMed ID: 17157317
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
[TBL] [Abstract][Full Text] [Related]
5. Dimerization of the human cytomegalovirus protease: kinetic and biochemical characterization of the catalytic homodimer.
Margosiak SA; Vanderpool DL; Sisson W; Pinko C; Kan CC
Biochemistry; 1996 Apr; 35(16):5300-7. PubMed ID: 8611517
[TBL] [Abstract][Full Text] [Related]
6. The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus.
Buisson M; Hernandez JF; Lascoux D; Schoehn G; Forest E; Arlaud G; Seigneurin JM; Ruigrok RW; Burmeister WP
J Mol Biol; 2002 Nov; 324(1):89-103. PubMed ID: 12421561
[TBL] [Abstract][Full Text] [Related]
7. A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities.
Buisson M; Géoui T; Flot D; Tarbouriech N; Ressing ME; Wiertz EJ; Burmeister WP
J Mol Biol; 2009 Aug; 391(4):717-28. PubMed ID: 19538972
[TBL] [Abstract][Full Text] [Related]
8. Analysis of proteinase specificity by studies of peptide substrates. The use of UV and fluorescence spectroscopy to quantitate rates of enzymatic cleavage.
Dunn BM; Scarborough PE; Davenport R; Swietnicki W
Methods Mol Biol; 1994; 36():225-43. PubMed ID: 7697110
[No Abstract] [Full Text] [Related]
9. Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase.
Murata T; Isomura H; Yamashita Y; Toyama S; Sato Y; Nakayama S; Kudoh A; Iwahori S; Kanda T; Tsurumi T
Virology; 2009 Jun; 389(1-2):75-81. PubMed ID: 19427010
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the substrate specificity of two potyvirus proteases.
Tözsér J; Tropea JE; Cherry S; Bagossi P; Copeland TD; Wlodawer A; Waugh DS
FEBS J; 2005 Jan; 272(2):514-23. PubMed ID: 15654889
[TBL] [Abstract][Full Text] [Related]
11. The role of the S-S bridge in retroviral protease function and virion maturation.
Zábranská H; Tůma R; Kluh I; Svatos A; Ruml T; Hrabal R; Pichová I
J Mol Biol; 2007 Feb; 365(5):1493-504. PubMed ID: 17140600
[TBL] [Abstract][Full Text] [Related]
12. A continuous assay for foot-and-mouth disease virus 3C protease activity.
Jaulent AM; Fahy AS; Knox SR; Birtley JR; Roqué-Rosell N; Curry S; Leatherbarrow RJ
Anal Biochem; 2007 Sep; 368(2):130-7. PubMed ID: 17631855
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling.
Frutos S; Rodriguez-Mias RA; Madurga S; Collinet B; Reboud-Ravaux M; Ludevid D; Giralt E
Biopolymers; 2007; 88(2):164-73. PubMed ID: 17236209
[TBL] [Abstract][Full Text] [Related]
14. Activity in monomers of human cytomegalovirus protease.
Holwerda B
Biochem Biophys Res Commun; 1999 Jun; 259(2):370-3. PubMed ID: 10362516
[TBL] [Abstract][Full Text] [Related]
15. Covalent immobilization of tobacco-etch-virus NIa protease: a useful tool for cleavage of the histidine tag of recombinant proteins.
Puhl AC; Giacomini C; Irazoqui G; Batista-Viera F; Villarino A; Terenzi H
Biotechnol Appl Biochem; 2009 May; 53(Pt 3):165-74. PubMed ID: 18937642
[TBL] [Abstract][Full Text] [Related]
16. Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.
Kuo CJ; Chi YH; Hsu JT; Liang PH
Biochem Biophys Res Commun; 2004 Jun; 318(4):862-7. PubMed ID: 15147951
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human cytomegalovirus protease dimerization by analytical centrifugation.
Cole JL
Biochemistry; 1996 Dec; 35(48):15601-10. PubMed ID: 8952514
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory kinetics of citric acid on beta-N-acetyl-d-glucosaminidase from prawn (Litopenaeus vannamei).
Xie XL; Hu YH; Wang LL; Chen CQ; Huang QS; Zhou HT; Chen QX
Fish Shellfish Immunol; 2010 Oct; 29(4):674-8. PubMed ID: 20624468
[TBL] [Abstract][Full Text] [Related]
20. Kosmotropic salt activation and substrate specificity of poliovirus protease 3C.
Gouvea IE; Judice WA; Cezari MH; Juliano MA; Juhász T; Szeltner Z; Polgár L; Juliano L
Biochemistry; 2006 Oct; 45(39):12083-9. PubMed ID: 17002308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
